These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27825770)

  • 21. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Arnett DK; Blumenthal RS; Albert MA; Buroker AB; Goldberger ZD; Hahn EJ; Himmelfarb CD; Khera A; Lloyd-Jones D; McEvoy JW; Michos ED; Miedema MD; Muñoz D; Smith SC; Virani SS; Williams KA; Yeboah J; Ziaeian B
    Circulation; 2019 Sep; 140(11):e596-e646. PubMed ID: 30879355
    [No Abstract]   [Full Text] [Related]  

  • 22. A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative.
    Hsu S; Ton VK; Dominique Ashen M; Martin SS; Gluckman TJ; Kohli P; Sisson SD; Blumenthal RS; Blaha MJ
    Clin Cardiol; 2013 Jul; 36(7):383-93. PubMed ID: 23670948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease.
    Muntner P; Orroth KK; Mues KE; Exter J; Shannon ED; Zaha R; Rosenson RS; Jackson EA
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):475-481. PubMed ID: 33661432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
    J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
    Bucheit JD; Helsing H; Nadpara P; Virani SS; Dixon DL
    J Clin Lipidol; 2018; 12(2):367-374.e3. PubMed ID: 29277495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.
    Grundy SM; Stone NJ;
    Ann Intern Med; 2019 Jun; 170(11):779-783. PubMed ID: 31132793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
    Wong ND; Budoff MJ; Ferdinand K; Graham IM; Michos ED; Reddy T; Shapiro MD; Toth PP
    Am J Prev Cardiol; 2022 Jun; 10():100335. PubMed ID: 35342890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    Virani SS; Newby LK; Arnold SV; Bittner V; Brewer LC; Demeter SH; Dixon DL; Fearon WF; Hess B; Johnson HM; Kazi DS; Kolte D; Kumbhani DJ; LoFaso J; Mahtta D; Mark DB; Minissian M; Navar AM; Patel AR; Piano MR; Rodriguez F; Talbot AW; Taqueti VR; Thomas RJ; van Diepen S; Wiggins B; Williams MS;
    Circulation; 2023 Aug; 148(9):e9-e119. PubMed ID: 37471501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Million hearts: prevalence of leading cardiovascular disease risk factors--United States, 2005-2012.
    Ritchey MD; Wall HK; Gillespie C; George MG; Jamal A;
    MMWR Morb Mortal Wkly Rep; 2014 May; 63(21):462-7. PubMed ID: 24871251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
    Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM
    Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
    Mortensen MB; Afzal S; Nordestgaard BG; Falk E
    J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
    Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutrition Intervention for Reduction of Cardiovascular Risk in African Americans Using the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines.
    Williams KA; Fughhi I; Fugar S; Mazur M; Gates S; Sawyer S; Patel H; Chambers D; McDaniel R; Reiser JR; Mason T
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016.
    Mufarreh A; Shah AJ; Vaccarino V; Kulshreshtha A
    JAMA Netw Open; 2023 Jan; 6(1):e2251156. PubMed ID: 36656581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin for primary prevention of cardiovascular disease: a review of recent literature and updated guideline recommendations.
    Mogul A; Leppien EE; Laughlin E; Spinler SA
    Expert Opin Pharmacother; 2021 Jan; 22(1):83-91. PubMed ID: 32924644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative.
    Ades PA; Keteyian SJ; Wright JS; Hamm LF; Lui K; Newlin K; Shepard DS; Thomas RJ
    Mayo Clin Proc; 2017 Feb; 92(2):234-242. PubMed ID: 27855953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    ; Virani SS; Newby LK; Arnold SV; Bittner V; Brewer LC; Demeter SH; Dixon DL; Fearon WF; Hess B; Johnson HM; Kazi DS; Kolte D; Kumbhani DJ; LoFaso J; Mahtta D; Mark DB; Minissian M; Navar AM; Patel AR; Piano MR; Rodriguez F; Talbot AW; Taqueti VR; Thomas RJ; van Diepen S; Wiggins B; Williams MS
    J Am Coll Cardiol; 2023 Aug; 82(9):833-955. PubMed ID: 37480922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
    Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
    Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.